MEDSEARCH TECHNOLOGIES INC
10QSB, EX-27, 2000-08-21
MEDICAL LABORATORIES
Previous: MEDSEARCH TECHNOLOGIES INC, 10QSB, 2000-08-21
Next: CHIPPAC INC, 10-Q, 2000-08-21



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
     CONDENSED BALANCE SHEET AS OF JUNE 30, 2000 AND THE RELATED CONDENSED
     STATEMENT OF OPERATIONS FOR THE SIX MONTH PERIOD ENDED JUNE 30, 2000 AND
     IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0001093759
<NAME>                        MEDSEARCH TECHNOLOGIES, INC.
<MULTIPLIER>                                             1
<CURRENCY>                                             USD

<S>                             <C>
<PERIOD-TYPE>                                  6-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                          1
<CASH>                                             132,398
<SECURITIES>                                             0
<RECEIVABLES>                                      523,441
<ALLOWANCES>                                       362,056
<INVENTORY>                                          6,900
<CURRENT-ASSETS>                                   369,231
<PP&E>                                             156,524
<DEPRECIATION>                                      50,340
<TOTAL-ASSETS>                                   1,783,244
<CURRENT-LIABILITIES>                              219,473
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                             6,534
<OTHER-SE>                                       1,057,237
<TOTAL-LIABILITY-AND-EQUITY>                     1,783,244
<SALES>                                            283,380
<TOTAL-REVENUES>                                   283,380
<CGS>                                               92,387
<TOTAL-COSTS>                                      768,566
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                  25,241
<INCOME-PRETAX>                                   (582,342)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                               (582,342)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                      (582,342)
<EPS-BASIC>                                          (0.09)
<EPS-DILUTED>                                        (0.09)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission